| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.4 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |